X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11388) 11388
Publication (865) 865
Book Review (167) 167
Book Chapter (88) 88
Conference Proceeding (28) 28
Book / eBook (20) 20
Magazine Article (17) 17
Dissertation (13) 13
Web Resource (11) 11
Newsletter (10) 10
Reference (6) 6
Paper (4) 4
Data Set (3) 3
Trade Publication Article (2) 2
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8199) 8199
index medicus (5966) 5966
dyslipidemia (5670) 5670
male (5038) 5038
female (4519) 4519
risk factors (3734) 3734
middle aged (3641) 3641
dyslipidemias - drug therapy (3234) 3234
adult (2633) 2633
cholesterol (2586) 2586
aged (2504) 2504
lipids (1906) 1906
dyslipidemias - blood (1778) 1778
diabetes (1678) 1678
dyslipidemias - complications (1605) 1605
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1572) 1572
animals (1535) 1535
statins (1534) 1534
atherosclerosis (1518) 1518
cardiovascular disease (1494) 1494
hypertension (1491) 1491
treatment outcome (1433) 1433
cardiac & cardiovascular systems (1429) 1429
metabolic syndrome (1411) 1411
coronary-heart-disease (1387) 1387
obesity (1350) 1350
cholesterol, ldl - blood (1333) 1333
hypolipidemic agents - therapeutic use (1321) 1321
cardiovascular diseases (1314) 1314
pharmacology & pharmacy (1311) 1311
cardiovascular-disease (1267) 1267
risk (1259) 1259
lipids - blood (1255) 1255
research (1253) 1253
dyslipidemias - epidemiology (1235) 1235
insulin resistance (1225) 1225
cardiovascular diseases - prevention & control (1155) 1155
triglycerides - blood (1141) 1141
prevalence (1135) 1135
dyslipidemias (1105) 1105
diabetes mellitus (1094) 1094
care and treatment (1086) 1086
endocrinology & metabolism (1033) 1033
health aspects (1021) 1021
cholesterol, hdl - blood (997) 997
triglycerides (978) 978
insulin-resistance (952) 952
prevention (942) 942
medicine, general & internal (927) 927
lipoproteins (925) 925
cardiovascular diseases - etiology (884) 884
mortality (871) 871
disease (855) 855
biomarkers - blood (829) 829
peripheral vascular disease (812) 812
cholesterol - blood (789) 789
low density lipoproteins (785) 785
body mass index (774) 774
risk-factors (771) 771
metabolism (766) 766
drug therapy (763) 763
analysis (734) 734
medicine (720) 720
type 2 diabetes (716) 716
inflammation (705) 705
therapy (705) 705
cross-sectional studies (698) 698
cardiovascular (696) 696
adolescent (694) 694
risk assessment (664) 664
dyslipidemias - therapy (660) 660
dyslipidemias - diagnosis (659) 659
atorvastatin (658) 658
blood pressure (658) 658
hypercholesterolemia (656) 656
time factors (643) 643
density-lipoprotein cholesterol (642) 642
drug therapy, combination (641) 641
retrospective studies (627) 627
glucose (626) 626
dyslipidemias - metabolism (625) 625
myocardial-infarction (624) 624
dyslipidemias - etiology (610) 610
management (594) 594
cardiovascular diseases - epidemiology (593) 593
young adult (583) 583
aged, 80 and over (580) 580
diet (579) 579
physiological aspects (579) 579
biochemistry & molecular biology (572) 572
rats (558) 558
comorbidity (556) 556
mice (556) 556
insulin (553) 553
research article (548) 548
abridged index medicus (544) 544
diabetes mellitus, type 2 - complications (541) 541
oxidative stress (541) 541
cardiovascular risk (540) 540
diabetes mellitus, type 2 - drug therapy (538) 538
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10588) 10588
Spanish (254) 254
Russian (142) 142
French (115) 115
Japanese (87) 87
Portuguese (65) 65
German (57) 57
Czech (41) 41
Chinese (38) 38
Polish (37) 37
Italian (27) 27
Korean (27) 27
Hungarian (18) 18
Croatian (10) 10
Turkish (10) 10
Romanian (5) 5
Lithuanian (3) 3
Swedish (3) 3
Ukrainian (3) 3
Arabic (2) 2
Danish (2) 2
Finnish (2) 2
Hebrew (2) 2
Slovak (2) 2
Belarusian (1) 1
Dutch (1) 1
Greek (1) 1
Norwegian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 05/2014, Volume 311, Issue 18, pp. 1870 - 1882
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 14, pp. 1785 - 1822
In 2016, the American College of Cardiology published the first expert consensus decision pathway (ECDP) on the role of non-statin therapies for low-density... 
PCSK9 inhibitors | lipids | ASCVD | bile acid sequestrants | ezetimibe | LDL-C | statins | cholesterol | dyslipidemia | ACC Expert Consensus Decision Pathway | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | HEART-FAILURE | SCIENTIFIC STATEMENT | REDUCING LIPIDS | DOUBLE-BLIND | EVOLOCUMAB | ROSUVASTATIN | Sequestering Agents - pharmacology | United States | Humans | Coronary Artery Disease - prevention & control | Enzyme Inhibitors - pharmacology | Ezetimibe - pharmacology | Cholesterol, LDL - analysis | Hypercholesterolemia - drug therapy | Consensus | Medication Therapy Management - organization & administration | Hypercholesterolemia - diagnosis | Anticholesteremic Agents - pharmacology | Cardiology - methods | Chemoprevention - methods | Decision-making | Usage | Task forces | Comorbidity | Low density lipoproteins | Coronary heart disease | Risk factors | Cardiovascular agents | Deoxycholic acid | Prevention | Hypercholesterolemia | Blood cholesterol | Cardiac patients | Diabetes | Universities and colleges | Cardiology | Statins | Lipoproteins (low density) | Clinical trials | Risk | Cardiovascular disease | Genetic screening | Atherosclerosis | Inhibition | Medical research | Risk groups | Decision making | Health risks | Subtilisin | Disease control | Patients | Low density lipoprotein | Cholesterol | Algorithms | Kexin | Inhibitors | Acids | Arteriosclerosis | Diagnostic systems | Cardiovascular diseases | Risk management
Journal Article
Circulation, ISSN 0009-7322, 04/2007, Volume 115, Issue 14, pp. 1948 - 1967
Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy,... 
Drugs | Pediatrics | Lipids | Hypercholesterolemia | AHA Scientific Statements | FACTOR INTERVENTION PROJECT | INTIMA-MEDIA THICKNESS | DEPENDENT DIABETES-MELLITUS | lipids | CARDIAC & CARDIOVASCULAR SYSTEMS | LOW-CHOLESTEROL DIET | drugs | LOW-DENSITY-LIPOPROTEIN | RESTORES ENDOTHELIAL FUNCTION | BODY-FAT DISTRIBUTION | hypercholesterolemia | BLOOD-PRESSURE | pediatrics | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | PERIPHERAL VASCULAR DISEASE | LOW-SATURATED-FAT | Dyslipidemias - complications | Humans | Hyperlipoproteinemias - epidemiology | Middle Aged | Child, Preschool | Male | Arteriosclerosis - epidemiology | Phytotherapy | Child | Dyslipidemias - diagnosis | Metabolic Syndrome - epidemiology | Arteriosclerosis - etiology | HIV Protease Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | Arteriosclerosis - diagnostic imaging | Risk Factors | Combined Modality Therapy | Disease Progression | Arteriosclerosis - prevention & control | Diet, Fat-Restricted | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hyperlipoproteinemia Type II - diet therapy | Adolescent | Age of Onset | HIV Infections - complications | Hypolipidemic Agents - therapeutic use | Arteriosclerosis - pathology | Cholesterol, Dietary | Dyslipidemias - diet therapy | Hyperlipoproteinemias - classification | Age Factors | Hyperlipoproteinemia Type II - diagnosis | Infant | Exercise Therapy | Contraindications | Dietary Fats | Hyperlipoproteinemias - drug therapy | Ultrasonography | Diabetes Complications - epidemiology | Adult | Cholesterol, LDL - blood | Female | Anticholesteremic Agents - classification | Hyperlipoproteinemia Type II - drug therapy | Hyperlipoproteinemia Type II - complications | Dyslipidemias - drug therapy | Clinical Trials as Topic | Anticholesteremic Agents - therapeutic use | Hyperlipoproteinemia Type II - epidemiology | Obesity - epidemiology | Hypolipidemic Agents - administration & dosage | HIV Infections - drug therapy | Hyperlipoproteinemias - genetics | Care and treatment | Demographic aspects | Hyperlipidemia | Research | Drug therapy | Risk factors
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
Abstract Objective Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents
Journal Article
Circulation Research, ISSN 0009-7330, 10/2018, Volume 123, Issue 9, pp. 1036 - 1038
HMG Co-A (beta-hydroxy beta-methylglutaryl-coenzyme A) reductase inhibitors (statins) were introduced in 1987 and have revolutionized the prevention and... 
cardiovascular disease | COST-EFFECTIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | patients | TRIAL | proprotein convertase subtilisin kexin 9 | DISEASE | cholesterol | PERIPHERAL VASCULAR DISEASE | dyslipidemia | HEMATOLOGY | human | EVOLOCUMAB | LIPIDS
Journal Article
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 04/2015, Volume 35, Issue 4, pp. 990 - 995
Journal Article
Journal Article